Steve Bates, BIA CEO
January 26, 2024 07:19 AM EST
Financing

UK's 're­silien­t' life sci­ences sec­tor hopes for up­turn af­ter de­creas­es in fi­nanc­ing, ven­ture cap­i­tal in 2023 — re­port

Katherine Lewin

News Reporter

The UK’s life sci­ences sec­tor took on an­oth­er tough year in 2023, see­ing de­creas­es in both eq­ui­ty fi­nanc­ing and raised ven­ture cap­i­tal, both of which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Evotec gains on Halozyme's takeover pro­pos­al

Adap­ti­m­mune to 're­de­fine' it­self as a sar­co­ma biotech, cuts a third of staffers

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

ALX On­col­o­gy hires Genen­tech, Mi­rati vet as CMO; Af­ter Car­mot, Heather Turn­er has three new roles on tap

Eli Lil­ly sues the US gov­ern­ment over its pro­posed 340B re­bate mod­el

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times